Thailand’s pharmaceutical market is seeing rapid growth in clinics, with sales for top multinationals rising at a 25% CAGR, surpassing USD 100 million in 2024 and reaching 40% of private hospital sales. Convenience, short wait times, and consumer willingness to pay out of pocket fuel this trend, while specialized clinics for office syndrome, aesthetics, and wellness expand demand. High-growth categories include diabetes drugs, vaccines, and dermacosmetics, though procurement and white-label use create challenges for branded products. With 20% of clinics driving 80% of sales, data-driven targeting is key. Clinics now represent a critical growth channel.

Join for free to read